| Literature DB >> 33293847 |
Xiao Fang1, Shu-Fang Duan1, Yu-Zhou Gong1, Fei Wang1, Xu-Lin Chen1.
Abstract
BACKGROUND: Patients with severe burns continue to display a high mortality rate during the initial shock period. The precise molecular mechanism underlying the change in host response during severe burn shock remains unknown. This study aimed to identify key genes leading to the change in host response during burn shock.Entities:
Keywords: burn shock; host response; immune response; in silico study
Year: 2020 PMID: 33293847 PMCID: PMC7718973 DOI: 10.2147/JIR.S282722
Source DB: PubMed Journal: J Inflamm Res ISSN: 1178-7031
Demographics of the Patients in Jonathan Plassais’s Study
| Patient ID | Sex | Age | TBSA | Endpoint at Day 28 |
|---|---|---|---|---|
| B01 | M | 52 | 85 | Non survivor |
| B02 | M | 40 | 85 | Survivor |
| B03 | M | 43 | 80 | Survivor |
| B04 | M | 36 | 73 | Survivor |
| B05 | M | 49 | 90 | Survivor |
| B06 | M | 42 | 88 | Non survivor |
| B07 | F | 75 | 40 | Survivor |
| B08 | F | 56 | 30 | Survivor |
| B09 | M | 50 | 49 | Survivor |
| B10 | F | 63 | 47 | Survivor |
| B11 | F | 49 | 35 | Survivor |
| B12 | M | 34 | 47 | Survivor |
| B13 | F | 48 | 64 | Non survivor |
| B14 | M | 48 | 75 | Survivor |
| B16 | F | 32 | 70 | Survivor |
| B17 | M | 66 | 35 | Survivor |
| B18 | M | 38 | 70 | Survivor |
| B20 | M | 41 | 46 | Non survivor |
| B21 | M | 35 | 88 | Survivor |
| B22 | M | 46 | 81 | Survivor |
| B23 | M | 48 | 62 | Survivor |
| B24 | M | 19 | 98 | Non survivor |
| B25 | M | 56 | 90 | Non survivor |
| B26 | M | 25 | 78 | Survivor |
| B27 | F | 64 | 38 | Survivor |
| B28 | M | 50 | 57 | Survivor |
| B30 | M | 46 | 57 | Non survivor |
| B31 | M | 47 | 50 | Survivor |
| B32 | F | 59 | 38 | Survivor |
| B19BY | F | 58 | 70 | Non survivor |
Abbreviations: M, male; F, female; TBSA, total burn surface area.
Figure 1DEGs from GSE77791. (A) 1059 DEGs are showed in the volcano plot that containing 551 upregulated genes in red and 508 downregulated genes in green. (B) The heatmap shows the top 100 most significant DEGs. Red indicates a relatively high expression and blue indicates a relatively low expression. DEGs were identified by the criteria of∣log2fold change (FC)∣>1 and adj. p. val <0.05. DEGs, differentially expressed gene.
Figure 2The GO terms and KEGG pathway enrichment analysis of all DEGs. (A) The top 8 terms enriched in BP, CC, and MF. (B) The top 8 enriched terms of KEGG pathway. Cutoff value is adj. p. val <0.05. GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed gene; BP, biological process; CC, cellular component; MF, molecular function.
GO Terms Enrichment Analysis of DEGs (Top 6 of Each)
| GO ID | Term | Adj. | Gene Count |
|---|---|---|---|
| Up-regulated | |||
| BP | |||
| GO:0043312 | neutrophil degranulation | 1.05E-49 | 91 |
| GO:0042119 | neutrophil activation | 1.05E-49 | 92 |
| GO:0002283 | neutrophil activation involved in immune response | 1.18E-49 | 91 |
| GO:0002446 | neutrophil mediated immunity | 6.62E-49 | 91 |
| GO:0050727 | regulation of inflammatory response | 6.76E-07 | 38 |
| GO:0097237 | cellular response to toxic substance | 0.000256 | 22 |
| CC | |||
| GO:0042581 | specific granule | 6.52E-34 | 46 |
| GO:0034774 | secretory granule lumen | 2.83E-30 | 57 |
| GO:0060205 | cytoplasmic vesicle lumen | 3.46E-29 | 57 |
| GO:0031983 | vesicle lumen | 3.46E-29 | 57 |
| GO:0030667 | secretory granule membrane | 7.23E-21 | 45 |
| GO:0035580 | specific granule lumen | 9.31E-20 | 23 |
| MF | |||
| GO:0016209 | antioxidant activity | 0.010493 | 11 |
| GO:0030246 | carbohydrate binding | 0.011884 | 20 |
| GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 0.022367 | 11 |
| GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors | 0.022367 | 8 |
| GO:0016757 | transferase activity, transferring glycosyl groups | 0.022518 | 19 |
| Down-regulated | |||
| BP | |||
| GO:0042110 | T cell activation | 1.79E-25 | 61 |
| GO:0030098 | lymphocyte differentiation | 2.48E-20 | 48 |
| GO:0030217 | T cell differentiation | 4.70E-20 | 40 |
| GO:0050852 | T cell receptor signaling pathway | 5.54E-18 | 35 |
| GO:0050851 | antigen receptor-mediated signaling pathway | 1.69E-17 | 42 |
| GO:0002429 | immune response-activating cell surface receptor signaling pathway | 1.16E-14 | 47 |
| CC | |||
| GO:0009897 | external side of plasma membrane | 7.71E-09 | 34 |
| GO:0001772 | immunological synapse | 4.86E-08 | 11 |
| GO:0042611 | MHC protein complex | 6.56E-06 | 8 |
| GO:0042613 | MHC class II protein complex | 8.65E-05 | 6 |
| GO:0098802 | plasma membrane receptor complex | 0.001032 | 20 |
| GO:0042101 | T cell receptor complex | 0.002005 | 12 |
| MF | |||
| GO:0023023 | MHC protein complex binding | 2.34E-06 | |
| GO:0023026 | MHC class II protein complex binding | 0.000391 | |
| GO:0019955 | cytokine binding | 0.000555 | |
| GO:0042605 | peptide antigen binding | 0.001138 | |
| GO:0019956 | chemokine binding | 0.001141 | |
| GO:0016493 | C-C chemokine receptor activity | 0.001423 | |
Abbreviations: GO, gene ontology; DEGs, differentially expressed genes; BP, biological process; CC, cellular component; MF, molecular function.
KEGG Pathway Enrichment Analysis of DEGs (Top 6 of Each)
| Pathway ID | Name | Adj. | Gene count |
|---|---|---|---|
| Up-regulated | |||
| hsa04610 | Complement and coagulation cascades | 0.000518 | 13 |
| hsa00480 | Glutathione metabolism | 0.04162 | 8 |
| hsa05202 | Transcriptional misregulation in cancer | 0.04162 | 15 |
| hsa00500 | Starch and sucrose metabolism | 0.04162 | 6 |
| hsa05150 | Staphylococcus aureus infection | 0.04162 | 10 |
| Down-regulated | |||
| hsa04658 | Th1 and Th2 cell differentiation | 2.68E-17 | 26 |
| hsa04659 | Th17 cell differentiation | 1.24E-13 | 24 |
| hsa04640 | Hematopoietic cell lineage | 1.70E-12 | 22 |
| hsa04612 | Antigen processing and presentation | 1.85E-09 | 17 |
| hsa05340 | Primary immunodeficiency | 1.22E-08 | 12 |
| hsa05332 | Graft-versus-host disease | 2.75E-08 | 12 |
Abbreviations: KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed gene.
Figure 3PPI network analysis. (A) The PPI network consists 439 nodes and 2430 edges were visualized in Cytoscape. Red notes the upregulated genes and green notes the downregulated genes. The size of each node is positive correlated with log2fold change (FC). The width of each edge is positively correlated with the combine score. (B) It shows the most significant modules in this PPI network. PPI, protein-protein interaction.
KEGG Pathway Enrichment Analysis of the DEGs in the Four Modules (Top 6 of Each)
| Cluster | Pathway ID | Name | Adj. | Gene Count |
|---|---|---|---|---|
| Module 1 | hsa05150 | Staphylococcus aureus infection | 0.000465 | 5 |
| Module 2 | hsa04062 | Chemokine signaling pathway | 3.14E-14 | 11 |
| hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 6.11E-11 | 8 | |
| hsa05163 | Human cytomegalovirus infection | 5.34E-10 | 9 | |
| hsa04060 | Cytokine-cytokine receptor interaction | 1.81E-07 | 8 | |
| hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 0.004247 | 3 | |
| hsa04024 | cAMP signaling pathway | 0.005765 | 4 | |
| Module 3 | hsa04120 | Ubiquitin mediated proteolysis | 2.65E-12 | 9 |
| hsa04141 | Protein processing in endoplasmic reticulum | 0.047101 | 3 | |
| Module 4 | hsa04658 | Th1 and Th2 cell differentiation | 5.38E-15 | 11 |
| hsa04659 | Th17 cell differentiation | 1.52E-14 | 11 | |
| hsa05340 | Primary immunodeficiency | 4.63E-13 | 8 | |
| hsa04660 | T cell receptor signaling pathway | 4.63E-13 | 10 | |
| hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 6.08E-12 | 9 | |
| hsa05162 | Measles | 1.20E-08 | 8 |
Abbreviations: KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed gene.
List of the Top 10 Hub Genes Selected by MCC, MNC, and Degree Methods in cytoHubba
| MCC | MNC | Degree |
|---|---|---|
Abbreviations: MCC, maximal clique centrality; MNC, maximum neighborhood component.
Figure 4Identification of the hub genes. (A) Hub genes were identified by the overlapping of the three methods in cytoHubba. (B) From the module analysis we find that seven of the hub genes upregulated and gathered in module 1 in which showed by shape of square.